stockgist
HomeTop MoversCompaniesConcepts

Market

  • Top Movers
  • Companies
  • Concepts

SEC Filings

  • AI Filing Analysis
  • Financial Reports
  • Current Reports
  • IPO Filings

Ownership

  • Institutional Holdings
  • Insider Trading

About

  • Data updates every 5 min
  • SEC EDGAR Source
© 2025–2026 StockGist|Information only, not investment advice
    1. Companies
    2. JWCAF
    stockgist
    HomeTop MoversCompaniesConcepts
    JWCAF logo

    James E. Wagner Cultivation Corporation

    JWCAF
    OTC
    Healthcare
    Drug Manufacturers - Specialty & Generic
    Kitchener, ON, CAjwc.ca
    —

    James E.

    —Mkt Cap
    —Rev TTM
    —NI TTM

    What Changed Recently

    No significant events in the past 90 days.

    Fundamentals

    How The Business Makes Money

    James E. Wagner Cultivation Corporation, through its subsidiary, James E. Wagner Cultivation Ltd., engages in the cultivation and sale of medical cannabis in Canada. The company focuses on producing clean, consistent cannabis using a proprietary aeroponic platform named GrowthSTORM. James E. Wagner Cultivation Corporation was founded in 2007 and is headquartered in Kitchener, Canada.

    Industry Drug Manufacturers - Specialty & Generic
    Analyst View

    Peer Companies

    CompanyPriceChangeMarket CapP/E
    BHNGFBhang Inc.————
    HEMPHemp, Inc————
    CNNACann American Corp.————
    FWDGFutureWorld Corp.————
    MJARFMJardin Group, Inc.————
    KOANResonate Blends, Inc.————
    OMIDOMID Holdings, Inc.————
    EVIOEVIO, Inc.————
    Company Profile
    CIKUNKNOWN_JWCAF
    ISINCA47031P1080
    Phone519 594-0144
    Address530 Trillium Drive, Kitchener, ON, N2R 1J4, CA
    SEC EDGAR

    Market

    • Top Movers
    • Companies
    • Concepts

    SEC Filings

    • AI Filing Analysis
    • Financial Reports
    • Current Reports
    • IPO Filings

    Ownership

    • Institutional Holdings
    • Insider Trading

    About

    • Data updates every 5 min
    • SEC EDGAR Source
    © 2025–2026 StockGist|Information only, not investment advice